KIDS · CIK 0001425450
What OrthoPediatrics Corp. told the SEC could break it.
2 self-disclosed vulnerabilities, pulled from its own filings — each in the company’s words, with the source. This is the risk register almost nobody reads.
A limited set so far — we surface every cited disclosure we’ve extracted for KIDS. More may follow as additional filings are processed.
In its own words
What could break it.
Other disclosures
- reliance on independent sales agencies & distributorsmedium
OrthoPediatrics relies on a network of independent sales agencies, stocking distributors and direct reps to market and distribute its products domestically and internationally; failure to maintain/expand that network would reduce sales.
“We rely on our network of independent sales agencies and distributors to market and distribute our products in both the United States and international markets.”
SEC filing →As of 2026
Regulatory & policy
- U.S. import tariffs (baseline 10%, Brazil 50%, EU 15%)medium
OrthoPediatrics is exposed to 2025 U.S. tariff actions — a 10% baseline reciprocal tariff, a 50% tariff on Brazilian imports (effective Aug 6, 2025), and a 15% EU-goods tariff — relevant to its Brazil, EU and UK operations and could raise product costs and reduce demand.
“On July 9, 2025, the United States announced plans to impose a 50% tariff on imports from Brazil, which became effective on August 6, 2025. On July 28, 2025, the United States and the European Union announced a trade agreement establishing a 15% tariff on most EU‑originating goods.”
The hidden graph
Who it depends on, and who depends on it.
Relationships surfaced from filings — including ones disclosed by the other side, which is how the non-obvious ones come to light.
Its suppliers
Structure Medical, LLC
“In addition to the mortgage with Squadron and its affiliate (refer to Note 9), we currently use Structure Medical, LLC”
Cited →
In the MyPRIA app, this is checked against the companies you actually own.
← World Watch